Rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. This phase 2 clinical trial sought to o... Visual Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus. Rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to con... Background: B-cell depletion with rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. We hy...
30 August 2022 in Portuguese Journal of Nephrology & Hypertension